Enabling True Personalization
Oncology
Patient-derived tumor organoids enable testing of multiple drugs and combinations to identify the most effective therapy before treatment begins.
Rare Disease
Create disease models from individual patients where no other models exist. Test potential therapies on the patient's own cells.
Pharmacogenomics
Functionally validate genetic variants affecting drug response. Move beyond prediction to actual testing on patient-derived cells.
Drug Sensitivity
Measure actual drug sensitivity profiles on patient cells to guide dose selection and avoid adverse reactions.
From Patient to Treatment Decision
Sample Collection
Blood draw, biopsy, or tumor sample provides cells for model creation.
Model Generation
Patient-derived organoids or iPSC-derived cells created within weeks.
Drug Testing
Multiple drugs and combinations tested on the patient's own cells.
Treatment Decision
Results guide selection of the most effective, safest treatment for that individual.